IDH2 and cancer: Moreover, the p-AMPK and p-STAT3 levels and VEGF expression were also reduced in TAMs of IDH2-deficient mice, indicating that most IDH2-deficient TAMs did not differentiate into M2 macrophages and that cancer progression was inhibited in IDH2-deficient mice (Fig. 6B).